Inicio>>Lipids>> Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids>>5S(6R)-EET

5S(6R)-EET (Synonyms: 5S(6R)-EpETrE,5S(6R)-epoxy-8(Z),11(Z),14(Z)-ETrE,5S(6R)-epoxy-all-cis-8,11,14-Eicosatrienoic Acid,5S(6R)-Epoxyeicosatrienoic Acid,FA 20:4;O)

Catalog No.GC91696

5S(6R)-EET is an oxylipin.

Products are for research use only. Not for human use. We do not sell to patients.

5S(6R)-EET Chemical Structure

Cas No.: 98103-47-0

Tamaño Precio Disponibilidad Cantidad
25 µg
402,00 $
Disponible
50 µg
724,00 $
Disponible
100 µg
1.285,00 $
Disponible
500 µg
5.625,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

5S(6R)-EET is an oxylipin. It depolarizes transepithelial voltage in isolated rabbit renal cortical collecting duct when applied to the luminal side at a concentration of 1 µM.[1] In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS.[2]

References:
[1].Sakairi, Y., Jacobson, H.R., Noland, T.D., et al.5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesisAm. J. Physiol.268(5 Pt 2)F931-F939(1995).
[2].Rashid, M., Manivet, P., Nishio, H., et al.Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modelingLife Sci.73(2)193-207(2003).

Reseñas

Review for 5S(6R)-EET

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5S(6R)-EET

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.